BOSTON SCIENTIFIC revenue for the last year amounted to 15.21 B CHF, the most of which — 9.73 B CHF — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 7.27 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought BOSTON SCIENTIFIC 9.27 B CHF, and the year before that — 7.09 B CHF.